CAO Xiang-Qi, HUO Kang, SONG Wen-Feng, LUO Guo-Gang, QU Qiu-Min. A Case of Trousseau's Syndrome Secondary to Lung Cancer with the Feature of Cerebral Infarction InvolvingMultiple Territory[J]. Chinese Journal of Stroke, 2021, 16(08): 843-849.
[1] LI M M，DATTO M，DUNCAVAGE EJ，et al.
Standards and guidelines for the interpretation and
reporting of sequence variants in cancer：a joint
consensus recommendation of the Association for
Molecular Pathology，American Society of Clinical
Oncology，and College of American Pathologists[J].
J Mol Diagn，2017，19（1）：4-23.
[2] TROUSSEAU A. Plegmasia alba dolens[M]//
TROUSSEAU A，BAZIRE P V，CORMACK J
R. Lectures on clinical medicine，delivered at the
Hotel-Dieu，Paris. London：New Sydenham Society，
1865：281-332.
[3] KHORANA A A. Malignancy，thrombosis and
Trousseau：the case for an eponym[J]. J Thromb
Haemost，2003，1（12）：2463-2465.
[4] YOUNG P，BRAVO M A，GONZALEZ M G，et al.
Armand Trousseau（1801-1867），his history and the
signs of hypocalcemia[J]. Rev Med Chil，2014，142
（10）：1341-1347.
[5] SACK G H，LEVIN J，BELL W R. Trousseaus
syndrome and other manifestations of chronic
disseminated coagulopathy in patients with
neoplasms-clinical，pathophysiologic，and
therapeutic features[J]. Medicine（Baltimore），1977，
56（1）：1-37.
[6] ADAMS H P，BENDIXEN B H，KAPPELLE L
J，et al. Classification of subtype of acute ischemic
stroke-definitions for use in a multicenter clinicaltrial[
J]. Stroke，1993，24（1）：35-41.
[7] 彭斌，吴波. 中国急性缺血性脑卒中诊治指南
2018[J]. 中华神经科杂志，2018，51（9）：666-682.
[8] TSUSHIMA M，METOKI N，HAGII J，et
al. D-dimer and C-reactive protein as potential
biomarkers for diagnosis of Trousseau's syndrome
in patients with cerebral embolism[J]. J Stroke
Cerebrovasc Dis，2020，29（2）：104534.
[9] MAI H，XIA J，WU Y J，et al. Clinical presentation
and imaging characteristics of occult lung cancer
associated ischemic stroke[J]. J Clin Neurosci，2015，
22（2）：296-302.
[10] SAMUEL S，REDDY S T，PARSHA K N，et al.
Routine surveillance of pelvic and lower extremity
deep vein thrombosis in stroke patients with patent
foramen ovale[J]. J Thromb Thrombolysis，2021，51
（4）：1150-1156.
[11] STRONGMAN H，GADD S，MATTHEWS
A，et al. Medium and long-term risks of specific
cardiovascular diseases in survivors of 20 adult
cancers：a population-based cohort study using
multiple linked UK electronic health records
databases[J]. Lancet，2019，394（10203）：1041-1054.
[12] CHEN P C，MUO C H，LEE Y T，et al. Lung Cancer
and Incidence of stroke a population-based cohort
study[J]. Stroke，2011，42（11）：3034-3039.
[13] YOON D W，SHIN D W，CHO J H，et al. Increased
risk of coronary heart disease and stroke in lung
cancer survivors：a Korean nationwide study of
20458 patients[J/OL]. Lung Cancer，2019，136：
115-121[2021-05-01]. https：//doi.org/10.1016/
j.lungcan.2019.08.025.
[14] SAITO E，INOUE M，SAWADA N，et al. Risk of
stroke in cancer survivors using a propensity scorematched
cohort analysis[J]. Sci Rep，2021，11（1）：
5599.
[15] HERKSUKEL M P P，SHANTAKUMAR S，
PENNING-VAN F J A，et al. Pulmonary embolism，
myocardial infarction，and ischemic stroke in lung
cancer patients：results from a longitudinal study[J].
Lung，2013，191（5）：501-509.
[16] 谢兴锐，秦超，陈莉，等. 肺癌相关脑梗死发病机制
的临床研究[J]. 中华内科杂志，2017，56（2）：99-
103.
[17] 应浩杰，王乃金，史进，等. 晚期非小细胞肺癌与脑
梗死关系的研究[J]. 中国实用神经疾病杂志，2017，
20（20）：85-89.
[18] KATO M，SHUKUYA T，MORI K，et al. Cerebral
infarction in advanced non-small cell lung cancer：a
case control study[J/OL]. BMC Cancer，2016，16：
203[2021-05-01]. https：//doi.org/10.1186/s12885-
016-2233-1.
[19] 杨启舟，付睿，王莉莉. 肿瘤相关脑梗死发病机制的
研究进展[J]. 中国卒中杂志，2021，16（2）：124-129.
[20] TACCONE F S，JEANGETTE S M，BLECIC S A.
First-ever stroke as initial presentation of systemic
cancer. Journal of stroke and cerebrovascular
diseases[J]. J Stroke Cerebrovasc Dis，2008，17（4）：
169-174.
[21] LEE M J，CHUNG J W，AHN M J，et al.
Hypercoagulability and mortality of patients with
stroke and active cancer：The OASIS-CANCER
Study[J]. Stroke，2017，19（1）：77-87.
[22] NONAGASE Y，TAKEDA M，TANAKA K，et al.
Treatment of EGFR mutation-positive non-small cell
lung cancer complicated by Trousseau syndrome
with gefitinib followed by osimertinib：a case
report[J]. Oncotarget，2018，9（50）：29532-29535.
[23] DAMMACCO F，VACCA A，PROCACCIO P，et
al. Cancer-related coagulopathy（Trousseau's
syndrome）：review of the literature and experience
of a single center of internal medicine[J]. Clin Exp
Med，2013，13（2）：85-97.
[24] CASTELLI R，PORRO F，TARSIA P，et al. The
heparins and cancer：review of clinical trials and
biological properties[J]. Vasc Med，2004，9（3）：
205-213.
[25] SHAMI K，GRIFFITHS E，STREIFF M.
Nonbacterial thrombotic endocarditis in cancer
patients：pathogenesis，diagnosis，and treatment[J].
Oncologist，2007，12（5）：518-523.
[26] BEYER-WESTENDORF J，WERTH S，
FOLPRECHT G，et al. Trousseau's syndrome in a
patient with adenocarcinoma of unknown primary
and therapy-resistant venous thrombosis treated with
dabigatran and fondaparinux[J]. Br J Clin Pharmacol，
2011，72（4）：715-716.
[27] 中国临床肿瘤学会肿瘤与血栓专家委员会. 肿瘤相关
静脉血栓栓塞症预防与治疗指南（2019版）[J]. 中国
肿瘤临床，2019，46（23）：1198.
[28] CHEN W B，HE Y B，SU Y Y. Multifocal cerebral
infarction as the first manifestation of occult
malignancy：case series of trousseau's syndrome and
literature review[J]. Brain Circ，2018，4（2）：65-72.
[29] CESTARI D M，WEINE D M，PANAGEAS K S，
et al. Stroke in patients with cancer-incidence and
etiology[J]. Neurology，2004，62（11）：2025-2030.
